A bioscience company founded in part by Dr. Andrew Wang, a physician scientist in the Department of Radiation Oncology at UNC, has secured millions of dollars in funding to facilitate the development of cancer diagnostics technology.
“Our goal is to have instant feedback to cancer treatment,” explained Wang.”[We want] cancer patients to have a diagnostic device.”
Wang founded Capio Biosciences with Dr. Seungpyo Hong after they attended a meeting held by the American Association for Cancer Research in 2010. That meeting led both professors to consider applications for the detection of circulating tumor cells.
“Seungpyo was responsible for […] making the device […] and my goal was to be on the clinical side,” noted Wang.
The device under development by Capio Biosciences captures tumor cells that circulate throughout the body after breaking off from cancer growths. According to Wang, these cells can be used to determine the effectiveness of cancer treatments.
“If [a cancer patient] started with 100 [circulating tumor cells captured by the device] and started with a treatment and [the tumor cell count] went to 130, then the implication is perhaps the treatment didn’t work and we should really think about doing something else,” explained Wang.
The US Food and Drug Administration approved a device for diagnosing circulating tumor cells in 2004 called CellSearch, but Wang claimed that Capio Biosciences will release a device that captures more circulating tumor cells than other diagnostic tools.
“We’re able to capture ten or even a hundred fold more than the established systems,” cited Wang.
Wang pitched the device to Betta Pharmaceuticals, a Chinese drug research and development company, in the spring of 2016. That pitch led to a funding agreement and international partnership that came to fruition last month with the assistance of other investors.
“Their investment validated what we have,” said Wang. “It’s a really synergistic partnership.”
Capio Biosciences will receive $2.9 million in equity financing along with another $1.6 million if the company reaches confidential performance milestones. According to Wang, Betta Pharmaceuticals gave the company “a very favorable investment term.”
In describing the conditions that paved the way for this deal, Wang noted that Capio Biosciences would not have made such progress without incorporating four years ago in North Carolina and taking advantage of resources provided by UNC.
“We wouldn’t have made it if weren’t for the innovation initiatives and entrepreneur initiatives at UNC,” relayed Wang.
Wang estimated that Capio Biosciences will begin nationwide clinical trials in three to five years. He was unable to give a definite timeline for the distribution of the device, but noted that “we want to get there as soon as possible.”
Related Stories
‹
![]()
Retired Banker Donates $4 Million to Cancer Research at UNCA retired executive who suffered the loss of three family members to cancer has made a donation of $4 million to the UNC Lineberger Comprehensive Cancer Center. Over the past decade, Alice Lehman watched her sister, husband and father succumb to the insidious effects of a disease that claims over 7 million lives each year. […]
![]()
Local Researchers Develop New Cancer-Fighting TechniqueA team of biomedical engineers working within a joint department of North Carolina State University and the University of North Carolina at Chapel Hill had their research published two weeks ago. According to Dr. Zhen Gu, the team’s senior author, the research focuses on using blood platelets to minimize the spread of cancer cells after […]
![]()
September 27, 2025This week, Dr. Deborah Stroman discusses the American Cancer Society's VOICES program, and is joined by Dr. Lauren E. McCullough (co-Principal Investigator for VOICES) and Elizabeth Williams (Duke WBB & WNBA Chicago Sky, Ambassador for VOICES).

District Veteran Rodney Trice Hired as Chapel Hill-Carrboro City Schools' New SuperintendentThe CHCCS Board of Education formally selected and approved Rodney Trice to be its next superintendent on Thursday night.

The Education Department Was Created To Ensure Equal Access. Who Would Do That in Its Absence?Without the Department of Education, advocates worry the federal government won't look out in the same way for poor or underserved students.

Orange County's NC Reps, Local Governments React to Anti-Diversity and Equity MeasuresAs a bill in the North Carolina House aims to ban diversity improvement efforts, local elected officials from Orange County are speaking out.

UNC Researchers Warn About Effects of Federal Funding Cuts on Cancer Discoveries, TreatmentsThreats of federal funding cuts are already felt within research circles at UNC, including the labs of some leading cancer research.

When RFK Jr. Was Presented With the Science on Vaccines He Said He Needed To See, He Dismissed ItRobert F. Kennedy Jr. spent insisted to senators that he’s not anti-vaccine. But he repeatedly refused to acknowledge scientific consensus.

The Rookery Opens on West Margaret Lane, Offering Cocktails and 'A Place to Nest'Hillsborough welcomed a new bar to its community over the weekend — as it formally started operations in the prominent former home of another popular bar. The Rookery officially opened to customers on Friday at 115 West Margaret Lane. The business is the latest venture of B.J. Patel, who is also behind the restaurant Nomad […]

'That Is The Point Of Higher Education': UNC Medical Professors Stress the IntangiblesShould college classes only focus on the skills that translate directly into higher pay? UNC medical professors agree: absolutely not.
›